Bi
Non verificato

BioArctic

Di cosa scriviamo

BiologiaEconomiaFarmaceuticaFitnessSanità
30/05/2026
Salute
Fitness
Media
Marketing
Comunicazione
Medicina - Varie
Number of shares and votes in BioArctic AB (publ) as of May 29, 2026
1.00
28/05/2026
Salute
Fitness
Media
Marketing
Comunicazione
Medicina - Varie
Bulletin from the Annual General Meeting in BioArctic AB (publ)
1.00
25/05/2026
Salute
Fitness
Media
Marketing
Comunicazione
Medicina - Varie
BioArctic's partner Eisai presents sales simulation of potential future sales of Leqembi® at its Investor Relations Day
1.00
20/05/2026
Salute
Fitness
Economia
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
BioArctic Interim Report for the period January - March 2026
1.00
15/05/2026
Salute
Fitness
Media
Marketing
Comunicazione
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Eisai projects Leqembi® revenue to total JPY 143.5 billion for fiscal year 2026 (April 2026 - March 2027)
1.00
13/05/2026
Salute
Fitness
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Telecomunicazioni
Invitation to presentation of BioArctic's first quarter report for January - March 2026 on May 20 at 9:30 a.m. CET
1.00
08/05/2026
Salute
Fitness
Imprese
Industria
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Leqembi® Iqlik™ PDUFA date updated to August 24 in the U.S.
1.00
21/04/2026
Salute
Fitness
Media
Marketing
Comunicazione
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
BioArctic publishes the Annual Report and Sustainability Report for 2025
1.00
23/03/2026
Salute
Fitness
Fiere
Eventi
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0